Literature DB >> 2199946

Insulin binding to brain capillaries is reduced in genetically obese, hyperinsulinemic Zucker rats.

M W Schwartz1, D F Figlewicz, S E Kahn, D G Baskin, M R Greenwood, D Porte.   

Abstract

In order to study the role of plasma insulin in regulating the binding of insulin to the endothelium of the blood-brain barrier (BBB), insulin binding to a purified preparation of brain capillaries was measured in both genetically obese Zucker rats and lean Zucker controls. We found a reduction of 65% in brain capillary insulin binding site number in the obese compared to lean rats with no change in receptor affinity. Furthermore, specific insulin binding to brain capillaries was negatively correlated (p less than 0.05) to the plasma insulin level, suggesting a role for plasma insulin in regulating insulin binding. A similar relationship was observed between insulin receptor number in liver membranes and the plasma insulin level. We conclude that obese, hyperinsulinemic Zucker rats exhibit a reduction in the number of BBB insulin receptors, which parallels the reduction seen in other peripheral tissues. Since insulin receptors have been hypothesized to participate in the transport of insulin across the BBB, the reduction observed in the obese rats may account for the decrease in cerebrospinal fluid insulin uptake previously demonstrated in these animals.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2199946     DOI: 10.1016/0196-9781(90)90044-6

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  40 in total

1.  Insulin enhances the gain of arterial baroreflex control of muscle sympathetic nerve activity in humans.

Authors:  Colin N Young; Shekhar H Deo; Kunal Chaudhary; John P Thyfault; Paul J Fadel
Journal:  J Physiol       Date:  2010-07-19       Impact factor: 5.182

2.  Insulin resistance is associated with poorer verbal fluency performance in women.

Authors:  Laura L Ekblad; Juha O Rinne; Pauli J Puukka; Hanna K Laine; Satu E Ahtiluoto; Raimo O Sulkava; Matti H Viitanen; Antti M Jula
Journal:  Diabetologia       Date:  2015-08-15       Impact factor: 10.122

3.  Low cerebrospinal fluid insulin levels in obese humans.

Authors:  W Kern; C Benedict; B Schultes; F Plohr; A Moser; J Born; H L Fehm; M Hallschmid
Journal:  Diabetologia       Date:  2006-09-02       Impact factor: 10.122

Review 4.  The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease.

Authors:  Sergio T Ferreira; William L Klein
Journal:  Neurobiol Learn Mem       Date:  2011-09-06       Impact factor: 2.877

5.  Insulin transport across the blood-brain barrier can occur independently of the insulin receptor.

Authors:  Elizabeth M Rhea; Christian Rask-Madsen; William A Banks
Journal:  J Physiol       Date:  2018-08-28       Impact factor: 5.182

Review 6.  Energy regulatory signals and food reward.

Authors:  Dianne P Figlewicz; Alfred J Sipols
Journal:  Pharmacol Biochem Behav       Date:  2010-03-15       Impact factor: 3.533

7.  CCK increases the transport of insulin into the brain.

Authors:  Aaron A May; Min Liu; Stephen C Woods; Denovan P Begg
Journal:  Physiol Behav       Date:  2016-08-26

8.  Central nervous insulin resistance: a promising target in the treatment of metabolic and cognitive disorders?

Authors:  M Hallschmid; B Schultes
Journal:  Diabetologia       Date:  2009-08-25       Impact factor: 10.122

9.  Effect of apolipoprotein E genotype and diet on apolipoprotein E lipidation and amyloid peptides: randomized clinical trial.

Authors:  Angela J Hanson; Jennifer L Bayer-Carter; Pattie S Green; Thomas J Montine; Charles W Wilkinson; Laura D Baker; G Stennis Watson; Laura M Bonner; Maureen Callaghan; James B Leverenz; Elaine Tsai; Nadia Postupna; Jing Zhang; Johanna Lampe; Suzanne Craft
Journal:  JAMA Neurol       Date:  2013-08       Impact factor: 18.302

10.  Estrogen and insulin transport through the blood-brain barrier.

Authors:  Aaron A May; Nicholas D Bedel; Ling Shen; Stephen C Woods; Min Liu
Journal:  Physiol Behav       Date:  2016-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.